Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Immune Efficiency, Interactions with Therapy and Administration of SARS-CoV-2 Vaccine in Patients with Cancer

Aired live on 9 February 2021

ESMO-Immune-Efficeiency-SARS-CoV-2-Vaccine-Webinar-1000x250

Immune Efficiency, Interactions with Therapy and Administration of SARS-CoV-2 Vaccine in Patients with Cancer

Chair: Ignacio Melero Bermejo
Speakers: Marie von Lilienfeld-Toal, Olivier Mir, Per Ljungman

Learning objectives: 

  • To elaborate the ability of cancer patients to generate immune responses to vaccines, indications and contraindications
  • To elaborate potential interactions between anticancer therapies and SARS-CoV-2 vaccines
  • To elaborate different problems related to SARS-CoV-2 vaccines timing of administration and duration of protection with an emphasis on cancer patients and developing countries

The programme was designed to offer expert opinion exchange and provide some considerations on key economic, ethical and societal aspects of prioritising the SARS-CoV-2 vaccination, as well as the balance between personal and societal freedoms, and special issues in vulnerable patient groups.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.